NCT00181116View on ClinicalTrials.gov

Levetiracetam for Benign Rolandic Epilepsy

PHASE4CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

September 30, 2006

Conditions

Epilepsy

Interventions

DRUG

Levetiracetam

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

UCB Pharma

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT00181116 - Levetiracetam for Benign Rolandic Epilepsy | Biotech Hunter | Biotech Hunter